Genome & Company Revenue

In the year 2025, Genome & Company had annual revenue of 24.59B KRW, down -11.38%. Genome & Company had revenue of 5.87B in the quarter ending December 31, 2025, a decrease of -18.89%.

Revenue

24.59B

Revenue Growth

-11.38%

P/S Ratio

9.01

Revenue / Employee

n/a

Employees

n/a

Market Cap

221.57B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	24.59B	-3.16B	-11.38%
Dec 31, 2024	27.74B	13.45B	94.07%
Dec 31, 2023	14.30B	211.39M	1.50%
Dec 31, 2022	14.08B	13.63B	3,021.27%
Dec 31, 2021	451.25M	300.66M	199.67%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
ISU Abxis	56.67B
ABION	880.14M
ViGenCell	278.95M
Ensol Biosciences	537.46M
Prestige Biologics	19.24B
Bio Solution	15.20B
QuadMedicine	10.70B
TiumBio	12.29B

Revenue Rankings